Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02928289 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma
A NA study, sponsored by Sight Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT02928289 is a NA study that was terminated before completion, run by Sight Sciences. The registered enrollment target is 29 participants.
The verdict
NCT02928289, a NA study, was terminated before completion, sponsored by Sight Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in reducing intraocular pressure (IOP) in adult, pseudophakic subjects with open-angle glaucoma.
Interventions
- DEVICE VISCO360 ab interno canaloplasty surgery
- DEVICE Selective Laser Trabeculoplasty (SLT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2017-01-23 |
| Est. Completion | 2019-01-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02928289
The ClinicalTrials.gov registry entry for NCT02928289 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sight Sciences, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which VISCO360 ab interno canaloplasty surgery is the first listed.
NCT02928289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02928289 about?
NCT02928289 is a clinical study titled "Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma". The purpose of this study is to evaluate the safety and effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in reducing intraocular pressure (IOP) in adult, pseudophakic subjects with open-angle glaucoma.
What is the current status of trial NCT02928289?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2017-01-23. Estimated completion is 2019-01-17.
What interventions are being tested in trial NCT02928289?
The interventions under investigation include: VISCO360 ab interno canaloplasty surgery (DEVICE), Selective Laser Trabeculoplasty (SLT) (DEVICE).
Who is sponsoring clinical trial NCT02928289?
This trial is sponsored by Sight Sciences, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.